Patrick A. Ozark
Impact in
-
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- Cancer-related gene regulation
- RNA modifications and cancer
- RNA Research and Splicing
- Protein Degradation and Inhibitors
- Histone Deacetylase Inhibitors Research
- Hematology top 10%
- Acute Myeloid Leukemia Research
Papers in
-
- Epigenetics and DNA Methylation 6
- Genomics and Chromatin Dynamics 6
- Cancer-related gene regulation 5
- Protein Degradation and Inhibitors 3
- RNA Research and Splicing 3
- Pluripotent Stem Cells Research 2
- Co-authors
- Ali Shilatifard (11 shared papers)Emily J. Rendleman (10 shared papers)Stacy A. Marshall (8 shared papers)Edwin R. Smith (7 shared papers)Marc A. Morgan (6 shared papers)Kaixiang Cao (5 shared papers)Clayton K. Collings (4 shared papers)Lu Wang (4 shared papers)
- Journals
- Science Advances (3 papers)Genes & Development (2 papers)Neuro-Oncology (1 paper)Nature Medicine (1 paper)Acta Neuropathologica Communications (1 paper)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Patrick A. Ozark
15 papers receiving 793 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 605
- Hematology 70
- Genetics 40
- Cancer Research 55
- Reproductive Medicine 30
Countries citing papers authored by Patrick A. Ozark
This map shows the geographic impact of Patrick A. Ozark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick A. Ozark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick A. Ozark more than expected).
Fields of papers citing papers by Patrick A. Ozark
This network shows the impact of papers produced by Patrick A. Ozark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick A. Ozark. The network helps show where Patrick A. Ozark may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick A. Ozark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 128 | |
| 2 | 2018 | 99 | |
| 3 | 2017 | 94 | |
| 4 | 2018 | 90 | |
| 5 | 2017 | 78 | |
| 6 | 2021 | 51 | |
| 7 | 2018 | 48 | |
| 8 | 2020 | 47 | |
| 9 | 2020 | 43 | |
| 10 | 2017 | 43 | |
| 11 | 2019 | 28 | |
| 12 | 2018 | 20 | |
| 13 | 2020 | 20 | |
| 14 | 2023 | 9 | |
| 15 | 2019 | 1 | |
| 16 | 2022 | 0 |
About Patrick A. Ozark
Patrick A. Ozark is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health, Hematology, Genetics and Genetics, having authored 16 papers that have together received 799 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Genomics and Chromatin Dynamics (6 papers), Cancer-related gene regulation (5 papers), Acute Myeloid Leukemia Research (3 papers), Protein Degradation and Inhibitors (3 papers), RNA Research and Splicing (3 papers), Pluripotent Stem Cells Research (2 papers) and Genetics and Neurodevelopmental Disorders (1 paper). The work is most often cited by research in Molecular Biology (605 citations), Hematology (70 citations), Genetics (40 citations), Cancer Research (55 citations) and Reproductive Medicine (30 citations). Patrick A. Ozark has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Ali Shilatifard, Emily J. Rendleman, Stacy A. Marshall, Edwin R. Smith, Marc A. Morgan, Kaixiang Cao, Clayton K. Collings, Lu Wang, Zibo Zhao and Lihua Zou. Their work appears in journals such as Science Advances, Genes & Development, Neuro-Oncology, Nature Medicine and Acta Neuropathologica Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.